Who invested in Atmo Biosciences

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2024, from 1 source

Latest round: VentureOct 2024
Investors: 1

See who backed them

The rounds

Oct 2024
VentureAmount undisclosed
- Brisbane Angels
Source recorded

Founders and team

From Atmo Biosciences's own website: 3 founders, 9 on the team.

Malcolm HebblewhitePresident & CEO, Co-Founder

Dr. James JohnHead of Research and Development/Product Development & Co-Founder

Dr. Kyle BereanHead of Clinical Affairs & Co-Founder

Martin ReidSenior Vice President, Sales
Dr. Carl RundeChief Financial Officer & Company Secretary
Dr. Ian MacfarlaneChief Operating Officer
Prof. William D. CheyChief of Gastroenterology and Hepatology.
Allison LockwoodHead of Quality and Regulatory
Assoc. Prof. Braden KuoBoard of Directors
Chris BertrandNon-Executive Director
Kate HillChair of the Board & Non-Executive Director
Tatsuaki OhashiNon-Executive Director

Everyone who backed them

Brisbane AngelsVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Atmo Biosciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.